ADC Therapeutics: Q1 Earnings Insights

ADC Therapeutics ADCT reported its Q1 earnings results on Monday, May 9, 2022 at 07:00 AM.

Here's what investors need to know about the announcement.

Earnings

ADC Therapeutics beat estimated earnings by 48.57%, reporting an EPS of $-0.36 versus an estimate of $-0.7.

Revenue was up $46.50 million from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.47 which was followed by a 4.67% drop in the share price the next day.

Here's a look at ADC Therapeutics's past performance:

To track all earnings releases for ADC Therapeutics visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.